
|Articles|November 1, 2012
Consider patients' concerns when treating autoimmune blistering disorders
If dermatologists considered the management of autoimmune blistering disorders from the patient's perspective, they might do many things differently. So says John Zone, M.D., co-director of the immunopathology lab at the University of Utah, where he is also chairman of dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
The Rx Recap: December 14-19
3
The Aesthetic Edge: December 2025
4
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
5

















